K Blennow Selected Research

GAP-43 Protein (GAP 43 Protein)

7/2018	Cerebrospinal fluid GAP-43 in early multiple sclerosis.
4/2017	CSF YKL-40 and GAP-43 are related to suicidal ideation in older women.
1/2000	CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging.
1/2000	Growth-associated protein GAP-43 in the frontal cortex and in the hippocampus in Alzheimer's disease: an immunohistochemical and quantitative study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Blennow Research Topics

Disease

67	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2000
25	Dementia (Dementias) 01/2021 - 01/2000
19	Cognitive Dysfunction 01/2018 - 11/2000
9	Atrophy 01/2017 - 01/2000
8	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 03/2001
8	Amyloid Plaque 02/2012 - 01/2000
7	Frontotemporal Dementia (Semantic Dementia) 07/2008 - 01/2000
6	Inflammation (Inflammations) 07/2018 - 01/2001
5	Multiple Sclerosis 11/2020 - 04/2009
5	Necrosis 04/2018 - 06/2001
5	Normal Pressure Hydrocephalus 07/2016 - 07/2000
5	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 03/2010 - 07/2000
4	Parkinson Disease (Parkinson's Disease) 01/2018 - 01/2000
4	Brain Diseases (Brain Disorder) 12/2014 - 03/2001
4	Schizophrenia (Dementia Praecox) 07/2007 - 01/2000
3	Tauopathies 01/2019 - 05/2000
3	Mental Disorders (Mental Disorder) 04/2007 - 03/2001
2	Disease Progression 01/2021 - 03/2004
2	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 05/2004
2	Neuroinflammatory Diseases 04/2018 - 04/2009
2	Parkinsonian Disorders (Parkinsonism) 01/2017 - 11/2015
2	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2008 - 11/2006
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2008 - 06/2000
2	Nervous System Diseases (Neurological Disorders) 01/2008 - 12/2007
1	Optic Neuritis (Retrobulbar Neuritis) 01/2021
1	Craniocerebral Trauma (Head Injury) 01/2019
1	Atrial Fibrillation 01/2019
1	Amyloidosis 12/2018
1	Guillain-Barre Syndrome 08/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2018
1	Neoplasms (Cancer) 04/2018
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Encephalitis (Encephalitis, Rasmussen) 01/2017
1	Autoimmune Diseases of the Nervous System 04/2016
1	Major Depressive Disorder (Major Depressive Disorders) 03/2016

Drug/Important Bio-Agent (IBA)

47	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2000
24	Amyloid (Amyloid Fibrils)IBA 01/2021 - 11/2000
23	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2000
16	Amyloid beta-PeptidesIBA 12/2009 - 11/2000
13	Apolipoproteins E (ApoE)IBA 01/2020 - 04/2000
11	tau Proteins (tau Protein)IBA 04/2016 - 11/2000
8	ApolipoproteinsIBA 01/2020 - 11/2000
6	CytokinesIBA 01/2013 - 11/2000
5	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2010 - 03/2001
4	Protein Isoforms (Isoforms)IBA 01/2020 - 07/2008
4	AlbuminsIBA 01/2019 - 01/2000
4	GAP-43 Protein (GAP 43 Protein)IBA 07/2018 - 01/2000
4	ButyrylcholinesteraseIBA 08/2011 - 06/2001
4	AcetylcholinesteraseIBA 08/2011 - 03/2001
4	Amino Acids FDA Link 07/2008 - 11/2000
3	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2000
3	Peptides (Polypeptides)IBA 01/2017 - 01/2008
3	Threonine (L-Threonine)FDA Link 10/2007 - 08/2002
3	Antipsychotic Agents (Antipsychotics)IBA 07/2007 - 01/2000
3	EsterasesIBA 01/2006 - 01/2001
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2004 - 09/2001
2	Serum AlbuminIBA 01/2019 - 04/2011
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 12/2014 - 01/2010
2	Apolipoprotein E4IBA 07/2014 - 01/2001
2	HomocysteineIBA 12/2013 - 05/2004
2	Neurofilament ProteinsIBA 04/2011 - 03/2007
2	CholesterolIBA 01/2011 - 01/2005
2	Pharmaceutical PreparationsIBA 10/2010 - 12/2005
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2010 - 06/2001
2	AcidsIBA 04/2009 - 10/2001
2	neurofilament protein LIBA 12/2007 - 05/2000
2	Glucose (Dextrose)FDA LinkGeneric 02/2007 - 02/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2006 - 01/2005
2	Kynurenic Acid (Kynurenate)IBA 12/2005 - 11/2001
2	Acetylcholine (Acetylcholine Chloride)FDA Link 09/2004 - 01/2001
2	InterleukinsIBA 08/2004 - 06/2001
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2004 - 09/2003
2	CarbonIBA 05/2004 - 01/2001
2	Biological ProductsIBA 03/2004 - 09/2000
2	amyloid beta-protein (1-42)IBA 03/2004 - 09/2002
2	Sulfoglycosphingolipids (Sulfatides)IBA 01/2004 - 07/2000
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2003 - 03/2001
2	Tacrine (Cognex)FDA Link 02/2003 - 01/2001
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2002 - 01/2001
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2002 - 01/2001
2	Presenilin-1IBA 07/2001 - 06/2001
1	Retinaldehyde (Retinal)IBA 01/2021
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2021
1	EpitopesIBA 01/2021
1	ChemokinesIBA 11/2020
1	NeurograninIBA 01/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019
1	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 08/2018
1	Therapeutic UsesIBA 07/2018
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	valylvaline (Val-Val)IBA 01/2018
1	ChitinasesIBA 01/2017
1	Natalizumab (Tysabri)FDA Link 01/2017
1	Glial Fibrillary Acidic ProteinIBA 04/2016
1	Glutamine (L-Glutamine)FDA Link 03/2016

Therapy/Procedure

2	Therapeutics 01/2019 - 07/2003
2	Catheters 01/2008 - 04/2007
2	Aftercare (After-Treatment) 11/2001 - 03/2001
1	Radiotherapy 04/2018
1	Cranial Irradiation 04/2018